1
|
Pereira-Silva GC, Cornélio CKCA, Pacheco G, Rochael NC, Gomes IAB, Cajado AG, Silva KC, Gonçalves BS, Temerozo JR, Bastos RS, Rocha JA, Souza LP, Souza MHLP, Lima-Júnior RCP, Medeiros JVR, Filgueiras MC, Bou-Habib DC, Saraiva EM, Nicolau LAD. Diminazene aceturate inhibits the SARS-CoV-2 spike protein-induced inflammation involving leukocyte migration and DNA extracellular traps formation. Life Sci 2024; 352:122895. [PMID: 38986896 DOI: 10.1016/j.lfs.2024.122895] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2024] [Revised: 06/16/2024] [Accepted: 07/03/2024] [Indexed: 07/12/2024]
Abstract
AIMS To investigate the SARS-CoV-2 Spike protein (Spk)-induced inflammatory response and its downmodulation by diminazene aceturate (DIZE). MATERIALS AND METHODS Through inducing Spk inflammation in murine models, leukocyte migration to the peritoneum, levels of myeloperoxidase (MPO), malondialdehyde (MDA), rolling and adhesion of mesenteric leukocytes, and vascular permeability were investigated. Extracellular DNA traps (DETs) induced by Spk and the production of IL-6 and TNF-α were analyzed using human neutrophils, monocytes, and macrophages. In silico assays assessed the molecular interaction between DIZE and molecules related to leukocyte migration and DETs induction. KEY FINDINGS Spk triggered acute inflammation, demonstrated by increasing leukocyte migration. Oxidative stress was evidenced by elevated levels of MPO and MDA in the peritoneal liquid. DIZE attenuated cell migration, rolling, and leukocyte adhesion, improved vascular barrier function, mitigated DETs, and reduced the production of Spk-induced pro-inflammatory cytokines. Computational studies supported our findings, showing the molecular interaction of DIZE with targets such as β2 integrin, PI3K, and PAD2 due to its intermolecular coupling. SIGNIFICANCE Our results outline a novel role of DIZE as a potential therapeutic agent for mitigating Spk-induced inflammation.
Collapse
Affiliation(s)
- Gean C Pereira-Silva
- Laboratory on Innate Immunity, Department of Immunology, Institute of Microbiology Paulo de Góes, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil
| | - Cassia K C A Cornélio
- Biotechnology and Biodiversity Center Research, Laboratory of Inflammation and Translational Gastroenterology, Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba, PI, Brazil
| | - Gabriella Pacheco
- Department of Biochemistry and Pharmacology, Health Sciences Center, Universidade Federal do Piauí (UFPI), Teresina, PI, Brazil
| | - Natalia C Rochael
- Laboratory on Innate Immunity, Department of Immunology, Institute of Microbiology Paulo de Góes, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil
| | - Isaac A B Gomes
- Biotechnology and Biodiversity Center Research, Laboratory of Inflammation and Translational Gastroenterology, Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba, PI, Brazil
| | - Aurilene G Cajado
- Department of Physiology and Pharmacology, Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil
| | - Katriane C Silva
- Biotechnology and Biodiversity Center Research, Laboratory of Inflammation and Translational Gastroenterology, Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba, PI, Brazil
| | | | - Jairo R Temerozo
- Laboratory on Thymus Research, Oswaldo Cruz Institute (Fiocruz), Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology on Neuroimmunemodulation, Rio de Janeiro, Brazil
| | - Ruan S Bastos
- Biotechnology and Biodiversity Center Research, Laboratory of Inflammation and Translational Gastroenterology, Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba, PI, Brazil
| | - Jefferson A Rocha
- Biotechnology and Biodiversity Center Research, Laboratory of Inflammation and Translational Gastroenterology, Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba, PI, Brazil
| | - Leonardo P Souza
- Biotechnology and Biodiversity Center Research, Laboratory of Inflammation and Translational Gastroenterology, Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba, PI, Brazil
| | - Marcellus H L P Souza
- Department of Physiology and Pharmacology, Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil
| | - Roberto C P Lima-Júnior
- Department of Physiology and Pharmacology, Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil
| | - Jand V R Medeiros
- Biotechnology and Biodiversity Center Research, Laboratory of Inflammation and Translational Gastroenterology, Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba, PI, Brazil; Department of Biochemistry and Pharmacology, Health Sciences Center, Universidade Federal do Piauí (UFPI), Teresina, PI, Brazil
| | - Marcelo C Filgueiras
- Biotechnology and Biodiversity Center Research, Laboratory of Inflammation and Translational Gastroenterology, Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba, PI, Brazil
| | - Dumith Chequer Bou-Habib
- Laboratory on Thymus Research, Oswaldo Cruz Institute (Fiocruz), Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology on Neuroimmunemodulation, Rio de Janeiro, Brazil
| | - Elvira M Saraiva
- Laboratory on Innate Immunity, Department of Immunology, Institute of Microbiology Paulo de Góes, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
| | - Lucas A D Nicolau
- Biotechnology and Biodiversity Center Research, Laboratory of Inflammation and Translational Gastroenterology, Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba, PI, Brazil; Department of Biochemistry and Pharmacology, Health Sciences Center, Universidade Federal do Piauí (UFPI), Teresina, PI, Brazil.
| |
Collapse
|
2
|
Araújo GSD, Moura AF, Barros AB, Moraes MO, Pessoa C, Perez CN, Castro MRCD, Ribeiro FDOS, Silva DAD, Sousa PSDA, Rocha JA, Marinho Filho JDB, Araujo AJ. Sulfonamide-chalcone hybrid compound suppresses cellular adhesion and migration: Experimental and computational insight. Chem Biol Interact 2024; 398:111115. [PMID: 38908811 DOI: 10.1016/j.cbi.2024.111115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2024] [Revised: 06/05/2024] [Accepted: 06/19/2024] [Indexed: 06/24/2024]
Abstract
In the present study, the effect of sulfonamide-chalcone 185 (SSC185) was investigated against B16-F10 metastatic melanoma cells aggressive actions, besides migration and adhesion processes, by in silico and in vitro assays. In silico studies were used to characterize the pharmacokinetic profile and possible targets of SSC185, using the pkCSM web server, and docking simulations with AutoDock Tools. Furthermore, the antimetastatic effect of SSC185 was investigated by in vitro experiments using MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide), colony, scratch, and cell adhesion assays, and atomic force microscopy (AFM). The molecular docking results show better affinity of SSC185 with the metalloproteinases-2 (MMP-2) and α5β1 integrin. SSC185 effectively restricts the formation of colonies, migration, and adhesion of B16-F10 metastatic melanoma cells. Through the AFM images changes in cells morphology was identified, with a decrease in the filopodia and increase in the average cellular roughness. The results obtained demonstrate the potential of this molecule in inhibit the primordial steps for metastasis, which is responsible for a worse prognosis of late stage cancer, being the main cause of morbidity among cancer patients.
Collapse
Affiliation(s)
- Gisele Santos de Araújo
- Laboratório de Cultura de Células do Delta, LCCDelta, Universidade Federal do Delta do Parnaíba, Parnaíba, PI, Brazil
| | - Andrea Felinto Moura
- Laboratório de Cultura de Células do Delta, LCCDelta, Universidade Federal do Delta do Parnaíba, Parnaíba, PI, Brazil
| | - Ayslan Batista Barros
- Laboratório de Cultura de Células do Delta, LCCDelta, Universidade Federal do Delta do Parnaíba, Parnaíba, PI, Brazil
| | - Manoel Odorico Moraes
- Departamento de Fisiologia e Farmacologia, Núcleo de Pesquisa e Desenvolvimento de Medicamentos - NPDM, Universidade Federal do Ceará, Fortaleza, CE, Brazil
| | - Claudia Pessoa
- Departamento de Fisiologia e Farmacologia, Núcleo de Pesquisa e Desenvolvimento de Medicamentos - NPDM, Universidade Federal do Ceará, Fortaleza, CE, Brazil
| | - Caridad Noda Perez
- Instituto de Química, Universidade Federal de Goiás, Goiânia, GO, Brazil
| | | | - Fábio de Oliveira Silva Ribeiro
- Núcleo de Pesquisa em Biodiversidade e Biotecnologia (BIOTEC), Universidade Federal do Delta do Parnaíba, Parnaíba, PI, Brazil
| | - Durcilene Alves da Silva
- Núcleo de Pesquisa em Biodiversidade e Biotecnologia (BIOTEC), Universidade Federal do Delta do Parnaíba, Parnaíba, PI, Brazil
| | - Paulo Sérgio de Araújo Sousa
- Grupo de Pesquisa em Química Medicinal e Biotecnologia, QUIMEBIO, Universidade Federal do Delta do Parnaíba, Parnaíba, PI, Brazil
| | - Jefferson Almeida Rocha
- Grupo de Pesquisa em Química Medicinal e Biotecnologia, QUIMEBIO, Universidade Federal do Delta do Parnaíba, Parnaíba, PI, Brazil
| | | | - Ana Jérsia Araujo
- Laboratório de Cultura de Células do Delta, LCCDelta, Universidade Federal do Delta do Parnaíba, Parnaíba, PI, Brazil.
| |
Collapse
|
3
|
Sousa PSDA, Rodrigues RRL, Souza VMRD, Araujo SSDM, Franco MSCR, Santos LBPD, Ribeiro FDOS, Paiva Junior JR, Araujo-Nobre ARD, Rodrigues KADF, Silva DAD, Feitosa JPDA, Perfeito MLG, Véras LMC, Rocha JA. Antimicrobial activity of nanoparticles based on carboxymethylated cashew gum and epiisopiloturine: In vitro and in silico studies. Int J Biol Macromol 2024; 274:133048. [PMID: 38857734 DOI: 10.1016/j.ijbiomac.2024.133048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2023] [Revised: 06/04/2024] [Accepted: 06/07/2024] [Indexed: 06/12/2024]
Abstract
Epiisopiloturine (EPI) is a compound found in jaborandi leaves with antiparasitic activity, which can be enhanced when incorporated into nanoparticles (NP). Cashew Gum (CG), modified by carboxymethylation, is used to produce polymeric nanomaterials with biological activity. In this study, we investigated the antimicrobial potential of carboxymethylated CG (CCG) NP containing EPI (NPCCGE) and without the alkaloid (NPCCG) against bacteria and parasites of the genus Leishmania. We conducted theoretical studies, carboxymethylated CG, synthesized NP by nanoprecipitation, characterized them, and tested them in vitro. Theoretical studies confirmed the stability of modified carbohydrates and showed that the EPI-4A30 complex had the best interaction energy (-8.47 kcal/mol). CCG was confirmed by FT-IR and presented DSabs of 0.23. NPCCG and NPCCGE had average sizes of 221.94 ± 144.086 nm and 247.36 ± 3.827 nm, respectively, with homogeneous distribution and uniform surfaces. No NP showed antibacterial activity or cytotoxicity to macrophages. NPCCGE demonstrated antileishmanial activity against L. amazonensis, both in promastigote forms (IC50 = 9.52 μg/mL, SI = 42.01) and axenic amastigote forms (EC50 = 6.6 μg/mL, SI = 60.60). The results suggest that nanostructuring EPI in CCG enhances its antileishmanial activity.
Collapse
Affiliation(s)
- Paulo Sérgio de Araujo Sousa
- Programa de Pós-Graduação em Biotecnologia, PPGBIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Grupo de Pesquisa em Química Medicinal e Biotecnologia, QUIMEBIO, Universidade Federal do Maranhão, UFMA, São Bernardo, Maranhão, MA, Brasil
| | - Raiza Raianne Luz Rodrigues
- Programa de Pós-Graduação em Biotecnologia, PPGBIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Laboratório de Doenças Infecciosas, LADIC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil
| | - Vanessa Maria Rodrigues de Souza
- Programa de Pós-Graduação em Biotecnologia, PPGBIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Laboratório de Doenças Infecciosas, LADIC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil
| | - Sansara Sanny de Mendonça Araujo
- Programa de Pós-Graduação em Biotecnologia, PPGBIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil
| | | | - Luma Brisa Pereira Dos Santos
- Programa de Pós-Graduação em Biotecnologia, PPGBIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil
| | - Fábio de Oliveira Silva Ribeiro
- Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil
| | - José Ribamar Paiva Junior
- Departamento de Química Orgânica e Inorgânica, Universidade Federal do Ceará, UFC, Fortaleza, Ceará, CE, Brasil
| | - Alyne Rodrigues de Araujo-Nobre
- Programa de Pós-Graduação em Biotecnologia, PPGBIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil
| | - Klinger Antonio da Franca Rodrigues
- Programa de Pós-Graduação em Biotecnologia, PPGBIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Laboratório de Doenças Infecciosas, LADIC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil
| | - Durcilene Alves da Silva
- Programa de Pós-Graduação em Biotecnologia, PPGBIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil
| | | | - Márcia Luana Gomes Perfeito
- Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil
| | - Leiz Maria Costa Véras
- Programa de Pós-Graduação em Biotecnologia, PPGBIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil
| | - Jefferson Almeida Rocha
- Programa de Pós-Graduação em Biotecnologia, PPGBIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Núcleo de Pesquisa em Biodiversidade e Biotecnologia, BIOTEC, Universidade Federal do Delta do Parnaíba, UFDPar, Parnaíba, Piauí, PI, Brasil; Grupo de Pesquisa em Química Medicinal e Biotecnologia, QUIMEBIO, Universidade Federal do Maranhão, UFMA, São Bernardo, Maranhão, MA, Brasil.
| |
Collapse
|
4
|
de Souza Silva MS, Dos Santos MLMF, da Silva AM, França WWM, Araújo SB, da Silva RL, do Nascimento WRC, da Silva Santos NP, da Cruz Filho IJ, de Azevedo Albuquerque MCP, de Araújo HDA, de Lima Aires A. Sanguinarine: an alkaloid with promising in vitro and in vivo antiparasitic activity against different developmental stages of Schistosoma mansoni and in silico pharmacokinetic properties (ADMET). Parasitol Res 2024; 123:143. [PMID: 38407619 DOI: 10.1007/s00436-024-08153-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2023] [Accepted: 02/02/2024] [Indexed: 02/27/2024]
Abstract
The objective of the study was to evaluate the in vitro and in vivo schistosomicidal activity of sanguinarine (SA) on Schistosoma mansoni and its in silico pharmacokinetic parameters. ADMET parameters and oral bioavailability were evaluated using the PkCSM and SwissADME platforms, respectively. The activity of SA in vitro, at the concentrations of 1.0-25 µM, was analyzed through the parameters of motility, mortality, and cell viability of the worms at intervals of 3-24 h. Mice were infected with cercariae and treated by gavage with SA (5 mg/kg/day, in a single dose or two doses of 2.5 mg/kg every 12 h for 5 consecutive days) on the 1st (skin schistosomula), 14th (pulmonary schistosomula), 28th (young worms), and 45th (adult worms) days after infection. In vitro and in vivo praziquantel was the control. In vitro, SA showed schistosomicidal activity against schistosomula, young worms, and couples; with total mortality and reduced cell viability at low concentrations and incubation time. In a single dose of 5 mg/kg/day, SA reduces the total worm load by 47.6%, 54%, 55.2%, and 27.1%, and female worms at 52.0%, 39.1%, 52.7%, and 20.2%, respectively, results which are similar to the 2.5 mg/kg/day dose. SA reduced the load of eggs in the liver, and in histopathological and histomorphometric analyses, there was a reduction in the number and volume of hepatic granulomas, which exhibited less inflammatory infiltrate. SA has promising in vitro and in vivo schistosomicidal activity against different developmental stages of S. mansoni, in addition to reducing granulomatous liver lesions. Furthermore, in silico, SA showed good predictive pharmacokinetic ADMET profiles.
Collapse
Affiliation(s)
- Maria Stéphanny de Souza Silva
- Centro de Biociências, Programa de Pós-Graduação Em Morfotecnologia, Universidade Federal de Pernambuco, Recife, PE, Brazil
- Instituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil
| | | | | | - Wilza Wanessa Melo França
- Instituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil
- Centro de Ciências Médicas, Programa de Pós-Graduação Em Medicina Tropical, Universidade Federal de Pernambuco, Recife, PE, Brazil
| | | | | | - Wheverton Ricardo Correia do Nascimento
- Centro de Biociências, Programa de Pós-Graduação Em Morfotecnologia, Universidade Federal de Pernambuco, Recife, PE, Brazil
- Instituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil
- Centro de Ciências Médicas, Área Acadêmica de Medicina Tropical, Universidade Federal de Pernambuco, Recife, PE, Brazil
| | - Noemia Pereira da Silva Santos
- Centro de Biociências, Programa de Pós-Graduação Em Morfotecnologia, Universidade Federal de Pernambuco, Recife, PE, Brazil
- Laboratório de Biotecnologia E Fármacos e Laboratório de Tecnologia de Biomateriais, Centro Acadêmico de Vitória de Santo Antão, Universidade Federal de Pernambuco, Vitória de Santo Antão, PE, Brazil
| | - Iranildo José da Cruz Filho
- Centro de Biociências, Programa de Pós-Graduação Em Morfotecnologia, Universidade Federal de Pernambuco, Recife, PE, Brazil
| | - Mônica Camelo Pessoa de Azevedo Albuquerque
- Instituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil
- Centro de Ciências Médicas, Área Acadêmica de Medicina Tropical, Universidade Federal de Pernambuco, Recife, PE, Brazil
| | - Hallysson Douglas Andrade de Araújo
- Instituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil
- Laboratório de Biotecnologia E Fármacos e Laboratório de Tecnologia de Biomateriais, Centro Acadêmico de Vitória de Santo Antão, Universidade Federal de Pernambuco, Vitória de Santo Antão, PE, Brazil
| | - André de Lima Aires
- Centro de Biociências, Programa de Pós-Graduação Em Morfotecnologia, Universidade Federal de Pernambuco, Recife, PE, Brazil.
- Instituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil.
- Centro de Ciências Médicas, Programa de Pós-Graduação Em Medicina Tropical, Universidade Federal de Pernambuco, Recife, PE, Brazil.
- Centro de Ciências Médicas, Área Acadêmica de Medicina Tropical, Universidade Federal de Pernambuco, Recife, PE, Brazil.
| |
Collapse
|
5
|
Liu Y, Tong JB, Gao P, Fan XL, Xiao XC, Xing YC. Combining QSAR techniques, molecular docking, and molecular dynamics simulations to explore anti-tumor inhibitors targeting Focal Adhesion Kinase. J Biomol Struct Dyn 2024:1-17. [PMID: 38173145 DOI: 10.1080/07391102.2023.2301055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2023] [Accepted: 12/15/2023] [Indexed: 01/05/2024]
Abstract
Focal Adhesion Kinase (FAK) is an important target for tumor therapy and is closely related to tumor cell genesis and progression. In this paper, we selected 46 FAK inhibitors with anticancer activity in the pyrrolo pyrimidine backbone to establish 3D/2D-QSAR models to explore the relationship between inhibitory activity and molecular structure. We have established two ideal models, namely, the Topomer CoMFA model (q 2 = 0.715, r 2 = 0.984) and the Holographic Quantitative Structure-Activity Relationship (HQSAR) model (q 2 = 0.707, r 2 = 0.899). Both models demonstrate excellent external prediction capabilities.Based on the QSAR results, we designed 20 structurally modified novel compounds, which were subjected to molecular docking and molecular dynamics studies, and the results showed that the new compounds formed many robust interactions with residues within the active pocket and could maintain stable binding to the receptor proteins. This study not only provides a powerful screening tool for designing novel FAK inhibitors, but also presents a series of novel FAK inhibitors with high micromolar activity that can be used for further characterization. It provides a reference for addressing the shortcomings of drug metabolism and drug resistance of traditional FAK inhibitors, as well as the development of novel clinically applicable FAK inhibitors.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Yuan Liu
- College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, China
- Shaanxi Key Laboratory of Chemical Additives for Industry, Shaanxi University of Science and Technology, Xi'an, China
| | - Jian-Bo Tong
- College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, China
- Shaanxi Key Laboratory of Chemical Additives for Industry, Shaanxi University of Science and Technology, Xi'an, China
| | - Peng Gao
- College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, China
- Shaanxi Key Laboratory of Chemical Additives for Industry, Shaanxi University of Science and Technology, Xi'an, China
| | - Xuan-Lu Fan
- College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, China
- Shaanxi Key Laboratory of Chemical Additives for Industry, Shaanxi University of Science and Technology, Xi'an, China
| | - Xue-Chun Xiao
- College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, China
- Shaanxi Key Laboratory of Chemical Additives for Industry, Shaanxi University of Science and Technology, Xi'an, China
| | - Yi-Chaung Xing
- College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, China
- Shaanxi Key Laboratory of Chemical Additives for Industry, Shaanxi University of Science and Technology, Xi'an, China
| |
Collapse
|
6
|
Souza HCA, Souza MDA, Sousa CS, Viana EKA, Alves SKS, Marques AO, Ribeiro ASN, de Sousa do Vale V, Islam MT, de Miranda JAL, da Costa Mota M, Rocha JA. Molecular Docking and ADME-TOX Profiling of Moringa oleifera Constituents against SARS-CoV-2. Adv Respir Med 2023; 91:464-485. [PMID: 37987297 PMCID: PMC10660866 DOI: 10.3390/arm91060035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Revised: 10/06/2023] [Accepted: 10/11/2023] [Indexed: 11/22/2023]
Abstract
The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2019) etiological agent, which has a high contagiousness and is to blame for the outbreak of acute viral pneumonia, is the cause of the respiratory disease COVID-19. The use of natural products grew as an alternative treatment for various diseases due to the abundance of organic molecules with pharmacological properties. Many pharmaceutical studies have focused on investigating compounds with therapeutic potential. Therefore, this study aimed to identify potential antiviral compounds from a popular medicinal plant called Moringa oleifera Lam. against the spike, Mpro, ACE2, and RBD targets of SARS-CoV-2. For this, we use molecular docking to identify the molecules with the greatest affinity for the targets through the orientation of the ligand with the receptor in complex. For the best results, ADME-TOX predictions were performed to evaluate the pharmacokinetic properties of the compounds using the online tool pkCSM. The results demonstrate that among the 61 molecules of M. oleifera, 22 molecules showed promising inhibition results, where the compound ellagic acid showed significant molecular affinity (-9.3 kcal.mol-1) in interaction with the spike protein. These results highlight the relevance of investigating natural compounds from M. oleifera as potential antivirals against SARS-CoV-2; however, additional studies are needed to confirm the antiviral activity of the compounds.
Collapse
Affiliation(s)
- Hellen Cris Araújo Souza
- Medicinal Chemistry and Biotechnology Research Group—QUIMEBIO, São Bernardo Science Center, Federal University of Maranhão UFMA, São Bernardo 65080-805, MA, Brazil; (H.C.A.S.); (M.D.A.S.); (C.S.S.); (E.K.A.V.); (S.K.S.A.); (A.O.M.); (A.S.N.R.); (V.d.S.d.V.); (M.d.C.M.); (J.A.R.)
| | - Maycon Douglas Araújo Souza
- Medicinal Chemistry and Biotechnology Research Group—QUIMEBIO, São Bernardo Science Center, Federal University of Maranhão UFMA, São Bernardo 65080-805, MA, Brazil; (H.C.A.S.); (M.D.A.S.); (C.S.S.); (E.K.A.V.); (S.K.S.A.); (A.O.M.); (A.S.N.R.); (V.d.S.d.V.); (M.d.C.M.); (J.A.R.)
| | - Cássio Silva Sousa
- Medicinal Chemistry and Biotechnology Research Group—QUIMEBIO, São Bernardo Science Center, Federal University of Maranhão UFMA, São Bernardo 65080-805, MA, Brazil; (H.C.A.S.); (M.D.A.S.); (C.S.S.); (E.K.A.V.); (S.K.S.A.); (A.O.M.); (A.S.N.R.); (V.d.S.d.V.); (M.d.C.M.); (J.A.R.)
| | - Edilanne Katrine Amparo Viana
- Medicinal Chemistry and Biotechnology Research Group—QUIMEBIO, São Bernardo Science Center, Federal University of Maranhão UFMA, São Bernardo 65080-805, MA, Brazil; (H.C.A.S.); (M.D.A.S.); (C.S.S.); (E.K.A.V.); (S.K.S.A.); (A.O.M.); (A.S.N.R.); (V.d.S.d.V.); (M.d.C.M.); (J.A.R.)
| | - Sabrina Kelly Silva Alves
- Medicinal Chemistry and Biotechnology Research Group—QUIMEBIO, São Bernardo Science Center, Federal University of Maranhão UFMA, São Bernardo 65080-805, MA, Brazil; (H.C.A.S.); (M.D.A.S.); (C.S.S.); (E.K.A.V.); (S.K.S.A.); (A.O.M.); (A.S.N.R.); (V.d.S.d.V.); (M.d.C.M.); (J.A.R.)
| | - Alex Oliveira Marques
- Medicinal Chemistry and Biotechnology Research Group—QUIMEBIO, São Bernardo Science Center, Federal University of Maranhão UFMA, São Bernardo 65080-805, MA, Brazil; (H.C.A.S.); (M.D.A.S.); (C.S.S.); (E.K.A.V.); (S.K.S.A.); (A.O.M.); (A.S.N.R.); (V.d.S.d.V.); (M.d.C.M.); (J.A.R.)
| | - Arthur Serejo Neves Ribeiro
- Medicinal Chemistry and Biotechnology Research Group—QUIMEBIO, São Bernardo Science Center, Federal University of Maranhão UFMA, São Bernardo 65080-805, MA, Brazil; (H.C.A.S.); (M.D.A.S.); (C.S.S.); (E.K.A.V.); (S.K.S.A.); (A.O.M.); (A.S.N.R.); (V.d.S.d.V.); (M.d.C.M.); (J.A.R.)
| | - Vanessa de Sousa do Vale
- Medicinal Chemistry and Biotechnology Research Group—QUIMEBIO, São Bernardo Science Center, Federal University of Maranhão UFMA, São Bernardo 65080-805, MA, Brazil; (H.C.A.S.); (M.D.A.S.); (C.S.S.); (E.K.A.V.); (S.K.S.A.); (A.O.M.); (A.S.N.R.); (V.d.S.d.V.); (M.d.C.M.); (J.A.R.)
| | - Muhammad Torequl Islam
- Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100, Bangladesh;
| | - João Antônio Leal de Miranda
- Department of Medicine, Senador Helvidio Nunes de Barros Center, Federal University of Piauí (UFPI), Picos 64607-670, PI, Brazil
| | - Marcelo da Costa Mota
- Medicinal Chemistry and Biotechnology Research Group—QUIMEBIO, São Bernardo Science Center, Federal University of Maranhão UFMA, São Bernardo 65080-805, MA, Brazil; (H.C.A.S.); (M.D.A.S.); (C.S.S.); (E.K.A.V.); (S.K.S.A.); (A.O.M.); (A.S.N.R.); (V.d.S.d.V.); (M.d.C.M.); (J.A.R.)
| | - Jefferson Almeida Rocha
- Medicinal Chemistry and Biotechnology Research Group—QUIMEBIO, São Bernardo Science Center, Federal University of Maranhão UFMA, São Bernardo 65080-805, MA, Brazil; (H.C.A.S.); (M.D.A.S.); (C.S.S.); (E.K.A.V.); (S.K.S.A.); (A.O.M.); (A.S.N.R.); (V.d.S.d.V.); (M.d.C.M.); (J.A.R.)
| |
Collapse
|
7
|
Otarigho B, Falade MO. Natural Perylenequinone Compounds as Potent Inhibitors of Schistosoma mansoni Glutathione S-Transferase. Life (Basel) 2023; 13:1957. [PMID: 37895339 PMCID: PMC10608284 DOI: 10.3390/life13101957] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2023] [Revised: 09/19/2023] [Accepted: 09/21/2023] [Indexed: 10/29/2023] Open
Abstract
The existing treatment strategy for Schistosomiasis centers on praziquantel, a single drug, but its effectiveness is limited due to resistance and lack of preventive benefits. Thus, there is an urgent need for novel antischistosomal agents. Schistosoma glutathione S-transferase (GST) is an essential parasite enzyme, with a high potential for targeted drug discovery. In this study, we conducted a screening of compounds possessing antihelminth properties, focusing on their interaction with the Schistosoma mansoni glutathione S-transferase (SmGST) protein. We demonstrated the unique nature of SmGST in comparison to human GST. Evolutionary analysis indicated its close relationship with other parasitic worms, setting it apart from free-living worms such as C. elegans. Through an assessment of binding pockets and subsequent protein-ligand docking, we identified Scutiaquinone A and Scutiaquinone B, both naturally derived Perylenequinones, as robust binders to SmGST. These compounds have exhibited effectiveness against similar parasites and offer promising potential as antischistosomal agents.
Collapse
Affiliation(s)
- Benson Otarigho
- Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA
| | | |
Collapse
|
8
|
Silva LMN, França WWM, Santos VHB, Souza RAF, Silva AM, Diniz EGM, Aguiar TWA, Rocha JVR, Souza MAA, Nascimento WRC, Lima Neto RG, Cruz Filho IJ, Ximenes ECPA, Araújo HDA, Aires AL, Albuquerque MCPA. Plumbagin: A Promising In Vivo Antiparasitic Candidate against Schistosoma mansoni and In Silico Pharmacokinetic Properties (ADMET). Biomedicines 2023; 11:2340. [PMID: 37760782 PMCID: PMC10525874 DOI: 10.3390/biomedicines11092340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Revised: 08/16/2023] [Accepted: 08/19/2023] [Indexed: 09/29/2023] Open
Abstract
Schistosomiasis, a potentially fatal chronic disease whose etiological agents are blood trematode worms of the genus Schistosoma spp., is one of the most prevalent and debilitating neglected diseases. The treatment of schistosomiasis depends exclusively on praziquantel (PZQ), a drug that has been used since the 1970s and that already has reports of reduced therapeutic efficacy, related with the development of Schistosoma-resistant or -tolerant strains. Therefore, the search for new therapeutic alternatives is an urgent need. Plumbagin (PLUM), a naphthoquinone isolated from the roots of plants of the genus Plumbago, has aroused interest in research due to its antiparasitic properties against protozoa and helminths. Here, we evaluated the in vivo schistosomicidal potential of PLUM against Schistosoma mansoni and the in silico pharmacokinetic parameters. ADMET parameters and oral bioavailability were evaluated using the PkCSM and SwissADME platforms, respectively. The study was carried out with five groups of infected mice and divided as follows: an untreated control group, a control group treated with PZQ, and three groups treated orally with 8, 16, or 32 mg/kg of PLUM. After treatment, the Kato-Katz technique was performed to evaluate a quantity of eggs in the feces (EPG). The animals were euthanized for worm recovery, intestine samples were collected to evaluate the oviposition pattern, the load of eggs was determined on the hepatic and intestinal tissues and for the histopathological and histomorphometric evaluation of tissue and hepatic granulomas. PLUM reduced EPG by 65.27, 70.52, and 82.49%, reduced the total worm load by 46.7, 55.25, and 72.4%, and the female worm load by 44.01, 52.76, and 71.16%, for doses of 8, 16, and 32 mg/kg, respectively. PLUM also significantly reduced the number of immature eggs and increased the number of dead eggs in the oogram. A reduction of 36.11, 46.46, and 64.14% in eggs in the hepatic tissue, and 57.22, 65.18, and 80.5% in the intestinal tissue were also observed at doses of 8, 16, and 32 mg/kg, respectively. At all doses, PLUM demonstrated an effect on the histopathological and histomorphometric parameters of the hepatic granuloma, with a reduction of 41.11, 48.47, and 70.55% in the numerical density of the granulomas and 49.56, 57.63, and 71.21% in the volume, respectively. PLUM presented itself as a promising in vivo antiparasitic candidate against S. mansoni, acting not only on parasitological parameters but also on hepatic granuloma. Furthermore, in silico, PLUM showed good predictive pharmacokinetic profiles by ADMET.
Collapse
Affiliation(s)
- Lucas M. N. Silva
- Programa de Pós-Graduação em Ciências Farmacêuticas, Departamento de Ciências Farmacêuticas, Universidade Federal de Pernambuco, Recife 50740-520, PE, Brazil; (L.M.N.S.); (V.H.B.S.); (R.A.F.S.); (E.C.P.A.X.); (M.C.P.A.A.)
| | - Wilza W. M. França
- Instituto Keizo Asami, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil; (W.W.M.F.); (A.M.S.); (E.G.M.D.); (T.W.A.A.); (J.V.R.R.); (W.R.C.N.); (H.D.A.A.)
- Programa de Pós-Graduação em Medicina Tropical, Departamento de Medicina Tropical Universidade Federal de Pernambuco, Recife 50670-420, PE, Brazil;
| | - Victor H. B. Santos
- Programa de Pós-Graduação em Ciências Farmacêuticas, Departamento de Ciências Farmacêuticas, Universidade Federal de Pernambuco, Recife 50740-520, PE, Brazil; (L.M.N.S.); (V.H.B.S.); (R.A.F.S.); (E.C.P.A.X.); (M.C.P.A.A.)
- Instituto Keizo Asami, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil; (W.W.M.F.); (A.M.S.); (E.G.M.D.); (T.W.A.A.); (J.V.R.R.); (W.R.C.N.); (H.D.A.A.)
| | - Renan A. F. Souza
- Programa de Pós-Graduação em Ciências Farmacêuticas, Departamento de Ciências Farmacêuticas, Universidade Federal de Pernambuco, Recife 50740-520, PE, Brazil; (L.M.N.S.); (V.H.B.S.); (R.A.F.S.); (E.C.P.A.X.); (M.C.P.A.A.)
- Instituto Keizo Asami, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil; (W.W.M.F.); (A.M.S.); (E.G.M.D.); (T.W.A.A.); (J.V.R.R.); (W.R.C.N.); (H.D.A.A.)
| | - Adriana M. Silva
- Instituto Keizo Asami, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil; (W.W.M.F.); (A.M.S.); (E.G.M.D.); (T.W.A.A.); (J.V.R.R.); (W.R.C.N.); (H.D.A.A.)
| | - Emily G. M. Diniz
- Instituto Keizo Asami, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil; (W.W.M.F.); (A.M.S.); (E.G.M.D.); (T.W.A.A.); (J.V.R.R.); (W.R.C.N.); (H.D.A.A.)
- Programa de Pós-Graduação em Medicina Tropical, Departamento de Medicina Tropical Universidade Federal de Pernambuco, Recife 50670-420, PE, Brazil;
| | - Thierry W. A. Aguiar
- Instituto Keizo Asami, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil; (W.W.M.F.); (A.M.S.); (E.G.M.D.); (T.W.A.A.); (J.V.R.R.); (W.R.C.N.); (H.D.A.A.)
- Departamento de Bioquímica, Universidade Federal de Pernambuco, Recife 50670-420, PE, Brazil
| | - João V. R. Rocha
- Instituto Keizo Asami, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil; (W.W.M.F.); (A.M.S.); (E.G.M.D.); (T.W.A.A.); (J.V.R.R.); (W.R.C.N.); (H.D.A.A.)
- Programa de Pós-Graduação em Medicina Tropical, Departamento de Medicina Tropical Universidade Federal de Pernambuco, Recife 50670-420, PE, Brazil;
| | - Mary A. A. Souza
- Programa de Pós-Graduação em Morfotecnologia, Departamento de Histologia e Embriologia, Universidade Federal de Pernambuco, Recife 50670-420, PE, Brazil; (M.A.A.S.); (I.J.C.F.)
| | - Wheverton R. C. Nascimento
- Instituto Keizo Asami, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil; (W.W.M.F.); (A.M.S.); (E.G.M.D.); (T.W.A.A.); (J.V.R.R.); (W.R.C.N.); (H.D.A.A.)
- Programa de Pós-Graduação em Morfotecnologia, Departamento de Histologia e Embriologia, Universidade Federal de Pernambuco, Recife 50670-420, PE, Brazil; (M.A.A.S.); (I.J.C.F.)
- Centro de Ciências Médicas—Área Acadêmica de Medicina Tropical, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil
| | - Reginaldo G. Lima Neto
- Programa de Pós-Graduação em Medicina Tropical, Departamento de Medicina Tropical Universidade Federal de Pernambuco, Recife 50670-420, PE, Brazil;
- Centro de Ciências Médicas—Área Acadêmica de Medicina Tropical, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil
| | - Iranildo J. Cruz Filho
- Programa de Pós-Graduação em Morfotecnologia, Departamento de Histologia e Embriologia, Universidade Federal de Pernambuco, Recife 50670-420, PE, Brazil; (M.A.A.S.); (I.J.C.F.)
- Departamento de Antibióticos, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil
| | - Eulália C. P. A. Ximenes
- Programa de Pós-Graduação em Ciências Farmacêuticas, Departamento de Ciências Farmacêuticas, Universidade Federal de Pernambuco, Recife 50740-520, PE, Brazil; (L.M.N.S.); (V.H.B.S.); (R.A.F.S.); (E.C.P.A.X.); (M.C.P.A.A.)
- Departamento de Antibióticos, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil
| | - Hallysson D. A. Araújo
- Instituto Keizo Asami, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil; (W.W.M.F.); (A.M.S.); (E.G.M.D.); (T.W.A.A.); (J.V.R.R.); (W.R.C.N.); (H.D.A.A.)
- Departamento de Bioquímica, Universidade Federal de Pernambuco, Recife 50670-420, PE, Brazil
| | - André L. Aires
- Instituto Keizo Asami, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil; (W.W.M.F.); (A.M.S.); (E.G.M.D.); (T.W.A.A.); (J.V.R.R.); (W.R.C.N.); (H.D.A.A.)
- Programa de Pós-Graduação em Medicina Tropical, Departamento de Medicina Tropical Universidade Federal de Pernambuco, Recife 50670-420, PE, Brazil;
- Programa de Pós-Graduação em Morfotecnologia, Departamento de Histologia e Embriologia, Universidade Federal de Pernambuco, Recife 50670-420, PE, Brazil; (M.A.A.S.); (I.J.C.F.)
- Centro de Ciências Médicas—Área Acadêmica de Medicina Tropical, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil
| | - Mônica C. P. A. Albuquerque
- Programa de Pós-Graduação em Ciências Farmacêuticas, Departamento de Ciências Farmacêuticas, Universidade Federal de Pernambuco, Recife 50740-520, PE, Brazil; (L.M.N.S.); (V.H.B.S.); (R.A.F.S.); (E.C.P.A.X.); (M.C.P.A.A.)
- Instituto Keizo Asami, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil; (W.W.M.F.); (A.M.S.); (E.G.M.D.); (T.W.A.A.); (J.V.R.R.); (W.R.C.N.); (H.D.A.A.)
- Centro de Ciências Médicas—Área Acadêmica de Medicina Tropical, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil
| |
Collapse
|
9
|
Synthetic hydrazones: In silico studies and in vitro evaluation of the antileishmania potential. Toxicol In Vitro 2023; 88:105560. [PMID: 36681287 DOI: 10.1016/j.tiv.2023.105560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Revised: 12/05/2022] [Accepted: 01/15/2023] [Indexed: 01/20/2023]
Abstract
Bioprospecting and synthesis of strategically designed molecules have been used in the search for drugs that can be in leishmaniasis. Hydrazones (HDZ) are promising compounds with extensive biological activities. The objective of this work was to perform in silico studies of hydrazones 1-5 and to evaluate their antileishmanial, cytotoxic and macrophage immunomodulatory potential in vitro. Hydrazones were subjected to prediction and molecular docking studies. Antileishmanial protocols on promastigotes and amastigotes of Leishmania amazonensis, cytotoxicity and macrophage immunomodulatory activity were performed. Hydrazones showed a good pharmacokinetic profile and hydrazone 3 and hydrazone 5 were classified as non-carcinogenic. Hydrazone 5 obtained the best conformation with trypanothione reductase. Hydrazone 1 and hydrazone 3 obtained the best mean inhibitory concentration (IC50) values for promastigotes, 4.4-61.96 μM and 8.0-58.75 μM, respectively. It also showed good activity on intramacrophagic amastigotes, with hydrazone 1 being the most active (IC50 = 6.79 μM) with selectivity index of 56. In cytotoxicity to macrophages hydrazone 3 was the most cytotoxic (CC50 = 256.3 ± 0,04 μM), while hydrazone 4 the least (CC50 = 1055.9 ± 0.03 μM). It can be concluded that the hydrazones revealed important pharmacokinetic and toxicological properties, in addition to antileishmania potential in reducing infection and infectivity in parasitized macrophages.
Collapse
|
10
|
Santos ES, Silva PC, Sousa PSA, Aquino CC, Pacheco G, Teixeira LFLS, Araujo AR, Sousa FBM, Barros RO, Ramos RM, Rocha JA, Nicolau LAD, Medeiros JVR. Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches. Chem Biol Interact 2022; 367:110161. [PMID: 36116513 PMCID: PMC9476334 DOI: 10.1016/j.cbi.2022.110161] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2021] [Revised: 08/30/2022] [Accepted: 09/01/2022] [Indexed: 11/05/2022]
Abstract
Diminazene aceturate (DIZE), an antiparasitic, is an ACE2 activator, and studies show that activators of this enzyme may be beneficial for COVID-19, disease caused by SARS-CoV-2. Thus, the objective was to evaluate the in silico and in vitro affinity of diminazene aceturate against molecular targets of SARS-CoV-2. 3D structures from DIZE and the proteases from SARS-CoV-2, obtained through the Protein Data Bank and Drug Database (Drubank), and processed in computer programs like AutodockTools, LigPlot, Pymol for molecular docking and visualization and GROMACS was used to perform molecular dynamics. The results demonstrate that DIZE could interact with all tested targets, and the best binding energies were obtained from the interaction of Protein S (closed conformation −7.87 kcal/mol) and Mpro (−6.23 kcal/mol), indicating that it can act both by preventing entry and viral replication. The results of molecular dynamics demonstrate that DIZE was able to promote a change in stability at the cleavage sites between S1 and S2, which could prevent binding to ACE2 and fusion with the membrane. In addition, in vitro tests confirm the in silico results showing that DIZE could inhibit the binding between the spike receptor-binding domain protein and ACE2, which could promote a reduction in the virus infection. However, tests in other experimental models with in vivo approaches are needed.
Collapse
Affiliation(s)
- Esley S Santos
- Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (LAFIDG), Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil; Medicinal Plants Research Center (NPPM), Federal University of Piauí, Teresina, Brazil
| | - Priscila C Silva
- Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (LAFIDG), Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil
| | - Paulo S A Sousa
- Laboratory of Medicinal Chemistry and Biotechnology, QUIMEBIO, Federal University of Maranhão, São Bernardo, MA, Brazil; Biodiversity and Biotechnology Research Center, BIOTEC, Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil
| | - Cristhyane C Aquino
- Postgraduate Program in Medical Sciences, Federal University of Ceará, Fortaleza, CE, Brazil
| | - Gabriella Pacheco
- Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (LAFIDG), Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil; Medicinal Plants Research Center (NPPM), Federal University of Piauí, Teresina, Brazil
| | - Luiz F L S Teixeira
- Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (LAFIDG), Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil; Biodiversity and Biotechnology Research Center, BIOTEC, Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil
| | - Alyne R Araujo
- Biodiversity and Biotechnology Research Center, BIOTEC, Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil
| | - Francisca B M Sousa
- Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (LAFIDG), Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil
| | - Romulo O Barros
- Research Laboratory in Information Systems, Department of Information, Environment, Health and Food Production, Federal Institute of Piauí, LaPeSI/IFPI, Teresina, Piauí, Brazil
| | - Ricardo M Ramos
- Research Laboratory in Information Systems, Department of Information, Environment, Health and Food Production, Federal Institute of Piauí, LaPeSI/IFPI, Teresina, Piauí, Brazil
| | - Jefferson A Rocha
- Laboratory of Medicinal Chemistry and Biotechnology, QUIMEBIO, Federal University of Maranhão, São Bernardo, MA, Brazil; Biodiversity and Biotechnology Research Center, BIOTEC, Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil
| | - Lucas A D Nicolau
- Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (LAFIDG), Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil; Biodiversity and Biotechnology Research Center, BIOTEC, Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil
| | - Jand V R Medeiros
- Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (LAFIDG), Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil; Medicinal Plants Research Center (NPPM), Federal University of Piauí, Teresina, Brazil; Biodiversity and Biotechnology Research Center, BIOTEC, Post-graduation Program in Biotechnology, Parnaíba Delta Federal University, Parnaíba, PI, Brazil.
| |
Collapse
|
11
|
Lima LR, Bastos RS, Ferreira EFB, Leão RP, Araújo PHF, Pita SSDR, De Freitas HF, Espejo-Román JM, Dos Santos ELVS, Ramos RDS, Macêdo WJC, Santos CBR. Identification of Potential New Aedes aegypti Juvenile Hormone Inhibitors from N-Acyl Piperidine Derivatives: A Bioinformatics Approach. Int J Mol Sci 2022; 23:ijms23179927. [PMID: 36077329 PMCID: PMC9456062 DOI: 10.3390/ijms23179927] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2022] [Revised: 08/18/2022] [Accepted: 08/18/2022] [Indexed: 11/16/2022] Open
Abstract
Aedes aegypti mosquitoes transmit several human pathogens that cause millions of deaths worldwide, mainly in Latin America. The indiscriminate use of insecticides has resulted in the development of species resistance to some such compounds. Piperidine, a natural alkaloid isolated from Piper nigrum, has been used as a hit compound due to its larvicidal activity against Aedes aegypti. In the present study, piperidine derivatives were studied through in silico methods: pharmacophoric evaluation (PharmaGist), pharmacophoric virtual screening (Pharmit), ADME/Tox prediction (Preadmet/Derek 10.0®), docking calculations (AutoDock 4.2) and molecular dynamics (MD) simulation on GROMACS-5.1.4. MP-416 and MP-073 molecules exhibiting ΔG binding (MMPBSA −265.95 ± 1.32 kJ/mol and −124.412 ± 1.08 kJ/mol, respectively) and comparable to holo (ΔG binding = −216.21 ± 0.97) and pyriproxyfen (a well-known larvicidal, ΔG binding= −435.95 ± 2.06 kJ/mol). Considering future in vivo assays, we elaborated the theoretical synthetic route and made predictions of the synthetic accessibility (SA) (SwissADME), lipophilicity and water solubility (SwissADME) of the promising compounds identified in the present study. Our in silico results show that MP-416 and MP-073 molecules could be potent insecticides against the Aedes aegypti mosquitoes.
Collapse
Affiliation(s)
- Lúcio R. Lima
- Graduate Program in Medicinal Chemistry and Molecular Modeling, Federal University of Pará, Belém 66075-110, PA, Brazil
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil
| | - Ruan S. Bastos
- Graduate Program in Medicinal Chemistry and Molecular Modeling, Federal University of Pará, Belém 66075-110, PA, Brazil
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil
| | - Elenilze F. B. Ferreira
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil
- Laboratory of Organic Chemistry and Biochemistry, University of the State of Amapá, Macapá 68900-070, AP, Brazil
| | - Rozires P. Leão
- Graduate Program in Medicinal Chemistry and Molecular Modeling, Federal University of Pará, Belém 66075-110, PA, Brazil
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil
| | - Pedro H. F. Araújo
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil
| | - Samuel S. da R. Pita
- Bioinformatics and Molecular Modeling Laboratory, Pharmacy College, Federal University of Bahia, Av. Barão de Jeremoabo, 147, Ondina, Salvador 40170-115, BA, Brazil
| | - Humberto F. De Freitas
- Bioinformatics and Molecular Modeling Laboratory, Pharmacy College, Federal University of Bahia, Av. Barão de Jeremoabo, 147, Ondina, Salvador 40170-115, BA, Brazil
- Health Department, State University of Feira de Santana, Feira de Santana 44036-900, BA, Brazil
| | - José M. Espejo-Román
- Department of Pharmaceutical and Organic Chemistry, Faculty of Pharmacy, Campus of Cartuja, University of Granada, 18071 Granada, Spain
| | - Edla L. V. S. Dos Santos
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil
| | - Ryan da S. Ramos
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil
| | - Williams J. C. Macêdo
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil
- Laboratory of Molecular Modeling and Simulation System, Federal Rural University of Amazônia, Rua João Pessoa, 121, Capanema 68700-030, PA, Brazil
| | - Cleydson B. R. Santos
- Graduate Program in Medicinal Chemistry and Molecular Modeling, Federal University of Pará, Belém 66075-110, PA, Brazil
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil
- Correspondence:
| |
Collapse
|
12
|
Dietary polysaccharides from guavira pomace, a co-product from the fruit pulp industry, display therapeutic application in gut disorders. Food Res Int 2022; 156:111291. [DOI: 10.1016/j.foodres.2022.111291] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 04/19/2022] [Accepted: 04/21/2022] [Indexed: 12/22/2022]
|
13
|
Figueiredo KA, Magalhães Costa RK, Rocha JA, Chavez Gutierrez SJ, Ramos RM, Muálem de Moraes Alves M, Aécio de Amorim Carvalho F, Menezes Carvalho AL, Lima FDCA. Antileishmanial activity of Riparin structural analogs of Aniba riparia: Biological evaluation, in silico Adme-Tox, and molecular docking. Exp Parasitol 2022; 236-237:108257. [DOI: 10.1016/j.exppara.2022.108257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2021] [Revised: 03/17/2022] [Accepted: 04/03/2022] [Indexed: 11/25/2022]
|
14
|
de Sousa NA, Marani MM, Lopes ALF, Silva EM, Barbosa EA, Vasconcelos AG, Kuzniewski FTB, Lustosa SS, Gomes KP, Colugnati DB, Rocha JA, Santos LH, Benquerer MP, Quelemes P, Véras L, Moreira DC, Gadelha KKL, Magalhães PJC, Plácido A, Eaton P, Nicolau L, Medeiros JVR, Leite JRSA. BR-bombesin: a novel bombesin-related peptide from the skin secretion of the Chaco tree frog (Boana raniceps) with physiological gastric effects. Amino Acids 2022; 54:733-747. [DOI: 10.1007/s00726-021-03114-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2021] [Accepted: 11/30/2021] [Indexed: 11/01/2022]
|
15
|
de Sá ÉRA, Souza JL, Costa RKM, Barros RO, de Lima CEB, Lima FDCA, Ramos RM. Computational investigation of the alkaloids of Pilocarpus microphyllus species as phytopharmaceuticals for the inhibition of sterol 14α-demethylase protease of Trypanosoma cruzi. J Biomol Struct Dyn 2022; 41:2555-2573. [PMID: 35132947 DOI: 10.1080/07391102.2022.2035819] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Trypanosoma cruzi is a protozoan transmitted by the insect Triatoma infestans, popularly known as kissing bug. This protozoan causes the Chagas disease, a Neglected Tropical Disease. This study aimed to investigate, through DFT method and B3LYP hybrid functional, the physicochemical, pharmacokinetic, and pharmacodynamic properties of the alkaloids present in the leaves of the species Pilocarpus microphyllus (jaborandi) as a potential inhibitory activity on the protease sterol 14α-demethylase of T. cruzi associated with the techniques of molecular docking, molecular dynamics, MM-PBSA and ADMET predictions. The molecules of isopilosine, epiisopiloturine, epiisopilosine, and pilosine showed up the lowest binding energies by molecular docking, good human intestinal absorption, low penetration in the blood-brain barrier, antiprotozoal and anticarcinogenic activities in ADMET studies. It has been observed a better binding affinity of the sterol 14α-demethylase protease with isopilosine in molecular dynamics and MM-PBSA studies, which indicates it as a potential drug candidate for Chagas disease.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Ézio R. A. de Sá
- Federal Institute of Education, Science and Technology of Piauí, IFPI, Picos, Piauí, Brazil
- Graduate Program in Chemistry, Federal University of Piauí, PPGQ/UFPI, Teresina, Piauí, Brazil
- Research Laboratory of the Computational Quantum Chemistry and Drug Planning Group, Chemistry Department, State University of Piauí, GQQC&PF/UESPI, Teresina, Piauí, Brazil
- Research Laboratory in Information Systems, Information Department, Environment, Health and Food Production, Federal Institute of Education, Science and Technology of Piauí, LaPeSI/IFPI, Teresina, Piauí, Brazil
| | - Janilson L. Souza
- Federal Institute of Education, Science and Technology of Maranhão, IFMA, Bacabal, Maranhão, Brazil
| | - Rayla K. M. Costa
- Research Laboratory of the Computational Quantum Chemistry and Drug Planning Group, Chemistry Department, State University of Piauí, GQQC&PF/UESPI, Teresina, Piauí, Brazil
| | - Rômulo O. Barros
- Research Laboratory in Information Systems, Information Department, Environment, Health and Food Production, Federal Institute of Education, Science and Technology of Piauí, LaPeSI/IFPI, Teresina, Piauí, Brazil
| | - Carlos E. B. de Lima
- University Hospital, Federal University of Piauí, Discipline of Cardiology, Department of General Practice - Cardiology and Health Sciences Center, DCG/CCS/UFPI, Teresina, Piauí, Brazil
| | - Francisco das C. A. Lima
- Research Laboratory of the Computational Quantum Chemistry and Drug Planning Group, Chemistry Department, State University of Piauí, GQQC&PF/UESPI, Teresina, Piauí, Brazil
| | - Ricardo M. Ramos
- Research Laboratory in Information Systems, Information Department, Environment, Health and Food Production, Federal Institute of Education, Science and Technology of Piauí, LaPeSI/IFPI, Teresina, Piauí, Brazil
| |
Collapse
|
16
|
de Menezes RPB, Viana JDO, Muratov E, Scotti L, Scotti MT. Computer-Assisted Discovery of Alkaloids with Schistosomicidal Activity. Curr Issues Mol Biol 2022; 44:383-408. [PMID: 35723407 PMCID: PMC8929062 DOI: 10.3390/cimb44010028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 01/08/2022] [Accepted: 01/09/2022] [Indexed: 11/28/2022] Open
Abstract
Schistosomiasis is a chronic parasitic disease caused by trematodes of the genus Schistosoma; it is commonly caused by Schistosoma mansoni, which is transmitted by Bioamphalaria snails. Studies show that more than 200 million people are infected and that more than 90% of them live in Africa. Treatment with praziquantel has the best cost–benefit result on the market. However, hypersensitivity, allergy, and drug resistance are frequently presented after administration. From this perspective, ligand-based and structure-based virtual screening (VS) techniques were combined to select potentially active alkaloids against S. mansoni from an internal dataset (SistematX). A set of molecules with known activity against S. mansoni was selected from the ChEMBL database to create two different models with accuracy greater than 84%, enabling ligand-based VS of the alkaloid bank. Subsequently, structure-based VS was performed through molecular docking using four targets of the parasite. Finally, five consensus hits (i.e., five alkaloids with schistosomicidal potential), were selected. In addition, in silico evaluations of the metabolism, toxicity, and drug-like profile of these five selected alkaloids were carried out. Two of them, namely, 11,12-methylethylenedioxypropoxy and methyl-3-oxo-12-methoxy-n(1)-decarbomethoxy-14,15-didehydrochanofruticosinate, had plausible toxicity, metabolomics, and toxicity profiles. These two alkaloids could serve as starting points for the development of new schistosomicidal compounds based on natural products.
Collapse
Affiliation(s)
- Renata Priscila Barros de Menezes
- Post-Graduate Program in Natural Synthetic Bioactive Products, Federal University of Paraiba, João Pessoa 58051-900, PB, Brazil; (R.P.B.d.M.); (J.d.O.V.); (L.S.)
| | - Jéssika de Oliveira Viana
- Post-Graduate Program in Natural Synthetic Bioactive Products, Federal University of Paraiba, João Pessoa 58051-900, PB, Brazil; (R.P.B.d.M.); (J.d.O.V.); (L.S.)
| | - Eugene Muratov
- Laboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA;
| | - Luciana Scotti
- Post-Graduate Program in Natural Synthetic Bioactive Products, Federal University of Paraiba, João Pessoa 58051-900, PB, Brazil; (R.P.B.d.M.); (J.d.O.V.); (L.S.)
| | - Marcus Tullius Scotti
- Post-Graduate Program in Natural Synthetic Bioactive Products, Federal University of Paraiba, João Pessoa 58051-900, PB, Brazil; (R.P.B.d.M.); (J.d.O.V.); (L.S.)
- Correspondence: ; Tel.: +55-83-998690415
| |
Collapse
|
17
|
Abo-Golayel M, Fatani A, Baothman O, Shash L, Abuaraki H, Zeyadi M, Hosawi S, Altayb H. Hepatoprotective effect of date palm fruit extract against doxorubicin intoxication in Wistar rats: In vivo and in silico studies. Asian Pac J Trop Biomed 2022. [DOI: 10.4103/2221-1691.350184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
18
|
Low CH, Mohamad H, Mustafa SFZ, Mohd KS, Mat Nafi NE. Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent. ARAB J CHEM 2022. [DOI: 10.1016/j.arabjc.2021.103510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022] Open
|
19
|
Nunes TADL, Santos MM, de Oliveira MS, de Sousa JMS, Rodrigues RRL, Sousa PSDA, de Araújo AR, Pereira ACTDC, Ferreira GP, Rocha JA, Rodrigues Junior V, da Silva MV, Rodrigues KADF. Curzerene antileishmania activity: Effects on Leishmania amazonensis and possible action mechanisms. Int Immunopharmacol 2021; 100:108130. [PMID: 34500286 DOI: 10.1016/j.intimp.2021.108130] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2021] [Revised: 08/27/2021] [Accepted: 09/01/2021] [Indexed: 11/26/2022]
Abstract
Leishmaniasis is a set of infectious diseases with high rates of morbidity and mortality, it affects millions of people around the world. Treatment, mainly with pentavalent antimonials, presents significant toxicity and many cases of resistance. In previous works we have demonstrated the effective and selective antileishmanial activity of Eugenia uniflora L. essential oil, being constituted (47.3%) by the sesquiterpene curzerene. Considering the high rate of parasite inhibition demonstrated for E. uniflora essential oil, and the significant presence of curzerene in the oil, this study aimed to evaluate its antileishmania activity and possible mechanisms of action. Curzerene was effective in inhibiting the growth of promastigotes (IC50 3.09 ± 0.14 µM) and axenic amastigotes (EC50 2.56 ± 0.12 µM), with low cytotoxicity to RAW 264.7 macrophages (CC50 83.87 ± 4.63 µM). It was observed that curzerene has direct effects on the parasite, inducing cell death by apoptosis with secondary necrotic effects (producing pores in the plasma membrane). Curzerene proved to be even more effective against intra-macrophage amastigote forms, with an EC50 of 0.46 ± 0.02 µM. The selectivity index demonstrated by curzerene on these parasite forms was 182.32, being respectively 44.15 and 8.47 times more selective than meglumine antimoniate and amphotericin B. The antiamastigote activity of curzerene was associated with immunomodulatory activity, as it increased TNF-α, IL-12, and NO levels, and lysosomal activity, and decreased IL-10 and IL-6 cytokine levels detected in macrophages infected and treated. In conclusion, our results demonstrate that curzerene is an effective and selective antileishmanial agent, a candidate for in vivo investigation in models of antileishmanial activity.
Collapse
Affiliation(s)
- Thaís Amanda de Lima Nunes
- Laboratório de Doenças Infecciosas, Campus Ministro Reis Velloso, Universidade Federal do Delta do Parnaíba, 64202-020 Parnaíba, PI, Brazil
| | - Malu Mateus Santos
- Laboratório de Imunologia e Parasitologia, Instituto de Ciências Biológicas e Naturais, Universidade Federal do Triângulo Mineiro, 38025-180 Uberaba, MG, Brazil
| | - Mariana Silva de Oliveira
- Laboratório de Imunologia e Parasitologia, Instituto de Ciências Biológicas e Naturais, Universidade Federal do Triângulo Mineiro, 38025-180 Uberaba, MG, Brazil
| | - Julyanne Maria Saraiva de Sousa
- Laboratório de Doenças Infecciosas, Campus Ministro Reis Velloso, Universidade Federal do Delta do Parnaíba, 64202-020 Parnaíba, PI, Brazil
| | - Raiza Raianne Luz Rodrigues
- Laboratório de Doenças Infecciosas, Campus Ministro Reis Velloso, Universidade Federal do Delta do Parnaíba, 64202-020 Parnaíba, PI, Brazil
| | - Paulo Sérgio de Araujo Sousa
- Núcleo de Pesquisa em Biotecnologia e Biodiversidade, Campus Ministro Reis Velloso, Universidade Federal do Delta do Parnaíba, 64202-020 Parnaíba, PI, Brazil
| | - Alyne Rodrigues de Araújo
- Núcleo de Pesquisa em Biotecnologia e Biodiversidade, Campus Ministro Reis Velloso, Universidade Federal do Delta do Parnaíba, 64202-020 Parnaíba, PI, Brazil
| | | | - Gustavo Portela Ferreira
- Laboratório de Biologia de Microrganismos, Campus Ministro Reis Velloso, Universidade Federal do Delta do Parnaíba, 64202-020 Parnaíba, PI, Brazil
| | - Jefferson Almeida Rocha
- Grupo de Pesquisa em Química Medicinal e Biotecnologia, QUIMEBIO, Universidade Federal do Maranhão, UFMA, São Bernardo, MA, Brazil
| | - Virmondes Rodrigues Junior
- Laboratório de Imunologia e Parasitologia, Instituto de Ciências Biológicas e Naturais, Universidade Federal do Triângulo Mineiro, 38025-180 Uberaba, MG, Brazil
| | - Marcos Vinicius da Silva
- Laboratório de Imunologia e Parasitologia, Instituto de Ciências Biológicas e Naturais, Universidade Federal do Triângulo Mineiro, 38025-180 Uberaba, MG, Brazil
| | - Klinger Antonio da Franca Rodrigues
- Laboratório de Doenças Infecciosas, Campus Ministro Reis Velloso, Universidade Federal do Delta do Parnaíba, 64202-020 Parnaíba, PI, Brazil.
| |
Collapse
|
20
|
Costa AN, de Sá ÉRA, Bezerra RDS, Souza JL, Lima FDCA. Constituents of buriti oil ( Mauritia flexuosa L.) like inhibitors of the SARS-Coronavirus main peptidase: an investigation by docking and molecular dynamics. J Biomol Struct Dyn 2021; 39:4610-4617. [PMID: 32567501 PMCID: PMC7332871 DOI: 10.1080/07391102.2020.1778538] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Accepted: 06/01/2020] [Indexed: 12/23/2022]
Abstract
Statistics show alarming numbers of infected and killed in the world, caused by the Covid-19 pandemic, which still doesn't have a specific treatment and effective in combating all efforts to seek treatments and medications against this disease. Natural products are of relevant interest in the search for new drugs. Thus, Buriti oil (Mauritia flexuosa L.) is a natural product extracted from the fruit of the palm and is quite common in the legal Amazon region, Brazil. In the present work, the anti-Covid-19 biological activity of some constituents of Buriti oil was investigated using in silico methods of Molecular Docking and Molecular Dynamics Simulations. The main results of Molecular Docking revealed favorable interaction energies in the formation of the 2GTB peptidase complex (main peptidase of SARS-CoV) with the 13-cis-β-carotene ligands (ΔGbind = -10.23Kcal mol-1), 9-cis -β-carotene (ΔGbind = -9.82Kcal mol-1), and α-carotene (ΔGbind = -8.34Kcal mol-1). Molecular Dynamics simulations demonstrated considerable interaction for these ligands with emphasis on α-carotene. Such theoretical results encourage and enable a direction for experimental studies in vitro and in vivo, essential in the development of new drugs with enzymatic inhibitory action for Covid-19.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Allan N. Costa
- Pará/Conceição do Araguaia Campus, Federal Institute of Education, Science and Technology, Conceição do Araguaia, Brazil
| | - Ézio R. A. de Sá
- Piauí/Picos Campus, Federal Institute of Education, Science and Technology, Picos, Brazil
| | - Roosevelt D. S. Bezerra
- Piauí/Teresina-Central Campus, Federal Institute of Education, Science and Technology, Teresina, Brazil
| | - Janilson L. Souza
- Maranhão/Bacabal Campus, Federal Institute of Education, Science and Technology, Bacabal, Brazil
| | | |
Collapse
|
21
|
Bahuguna A, Bharadwaj S, Bajpai VK, Shukla S, Won DW, Park I, Na M, Sonwal S, Huh YS, Han YK, Simal-Gandara J, Xiao J, Kim M. Insights into cyclooxygenase-2 inhibition by isolated bioactive compounds 3-caffeoyl-4-dihydrocaffeoyl quinic acid and isorhamnetin 3-O-β-D-glucopyranoside from Salicornia herbacea. PHYTOMEDICINE 2021; 90:153638. [PMID: 34275700 DOI: 10.1016/j.phymed.2021.153638] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/04/2021] [Revised: 06/14/2021] [Accepted: 06/20/2021] [Indexed: 02/08/2023]
Abstract
BACKGROUND Cyclooxygenase-2 (COX-2) is an important enzyme with numerous biological functions. Overexpression of COX-2 has been associated with various inflammatory-related diseases and therefore, projected as an important pharmacological target. PURPOSE We aimed to investigate the inhibitory potential of isolated bioactive compounds, 3-caffeoyl-4-dihydrocaffeoyl quinic acid (CDQ) and isorhamnetin 3-O-β-d-glucopyranoside (IDG), from Salicornia herbacea against COX-2 using both computational and in vitro approaches. METHODS Computational analysis, including molecular docking, molecular dynamics (MD) simulations, and post-simulations analysis, were employed to estimate the binding affinity and stability of CDQ and IDG in the catalytic pocket of COX-2 against Celecoxib as positive control. These predictions were further evaluated using in vitro enzyme inhibition as well as gene expression mediation in macrophages cells. RESULTS Molecular docking analysis revealed substantial binding energy of CDQ (-6.1 kcal/mol) and IDG (-5.9 kcal/mol) with COX-2, which are lower than Celecoxib (-8.1 kcal/mol). MD simulations (100 ns) and post simulation analysis exhibited the substantial stability and binding affinity of docked CDQ and IDG compounds with COX-2. In vitro assays indicated significant COX-2 inhibition by CDQ (IC50 = 76.91 ± 2.33 μM) and IDG (IC50 = 126.06 ± 9.44 μM). This result supported the inhibitory potential of isolated bioactive compounds against COX-2. Also, a cellular level study revealed a downregulation of COX-2 expression in tumor necrosis factor-alpha stimulated RAW 264.7 macrophages treated with CDQ and IDG. CONCLUSION Computational and experimental analysis of CDQ and IDG from S. herbacea established their potential in the inhibition and mediation of COX-2. Hence, CDQ and IDG can be considered for therapeutic development against COX-2 linked disorders, such as inflammation and cancer. Furthermore, CDQ and IDG structures can be served as a lead compound for the development of advanced novel anti-inflammatory drugs.
Collapse
Affiliation(s)
- Ashutosh Bahuguna
- Department of Food Science and Technology, Yeungnam University, Gyeongsan, Gyeongsangbuk-do 38541, South Korea
| | - Shiv Bharadwaj
- Nanotechnology Research and Application Center, Sabanci University, Istanbul 34956, Turkey
| | - Vivek K Bajpai
- Department of Energy and Materials Engineering, Dongguk University, Seoul 04620, South Korea
| | - Shruti Shukla
- TERI-Deakin Nanobiotechnology Centre, The Energy and Resources Institute, Gwal Pahari, Gurugram, Haryana 122003, India
| | - Dong Wook Won
- College of Pharmacy, Chungnam National University, Daejeon 34134, South Korea
| | - InWha Park
- Natural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung, Gangwon-do 25451, South Korea
| | - MinKyun Na
- College of Pharmacy, Chungnam National University, Daejeon 34134, South Korea.
| | - Sonam Sonwal
- Department of Biological Engineering, Biohybrid Systems Research Center (BSRC), Inha University, Incheon 22212, South Korea
| | - Yun Suk Huh
- Department of Biological Engineering, Biohybrid Systems Research Center (BSRC), Inha University, Incheon 22212, South Korea.
| | - Young-Kyu Han
- Department of Energy and Materials Engineering, Dongguk University, Seoul 04620, South Korea.
| | - Jesus Simal-Gandara
- Department of Analytical Chemistry and Food Science, University of Vigo - Ourense Campus, E-32004 Ourense, Spain
| | - Jianbo Xiao
- Department of Analytical Chemistry and Food Science, University of Vigo - Ourense Campus, E-32004 Ourense, Spain; International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang 212013, China.
| | - Myunghee Kim
- Department of Food Science and Technology, Yeungnam University, Gyeongsan, Gyeongsangbuk-do 38541, South Korea; Research Institute of Cell Culture, Yeungnam University, Gyeongsan, Gyeongsangbuk-do 38541, South Korea.
| |
Collapse
|
22
|
Antimicrobial, modulatory, and antibiofilm activity of tt-farnesol on bacterial and fungal strains of importance to human health. Bioorg Med Chem Lett 2021; 47:128192. [PMID: 34118413 DOI: 10.1016/j.bmcl.2021.128192] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2021] [Revised: 06/03/2021] [Accepted: 06/06/2021] [Indexed: 11/20/2022]
Abstract
In this study, we analyzed the antimicrobial, antibiofilm, and modulatory activities of trans-trans-farnesol (tt-farnesol). The minimum inhibitory concentration (MIC) of this sesquiterpene was evaluated against 31 Gram-positive and Gram-negative bacterial strains and 4 species of the genus Candida. Furthermore, we examined its inhibitory action on biofilm production as well as antibiotic modulation. Only Gram-positive species presented susceptibility to tt-farnesol (MIC ranging from 8 µg/mL to 128 µg/mL). No synergistic or antagonistic effects were observed between tt-farnesol (1/4 and 1/8 of MIC) and first-choice antibiotics against multidrug resistant strains. However, the modulatory action of tt-farnesol (1/2 and 1/4 of the MIC) decreased 8 × MIC of non-inhibitory β-lactam antibiotic against a Methicillin-resistant strain. In the antibiofilm assay, tt-farnesol inhibited biofilm formation, especially in Methicillin-resistant Staphylococcus aureus (MRSA) strains, at concentrations ranging from 2 μg/mL to 128 μg/mL. Additionally, in the molecular docking study, the tt-farnesol molecule demonstrated a remarkable binding affinity with important proteins involved in the biofilm production, such as IcaA and Srt proteins. The antimicrobial action of tt-farnesol on Streptococcus pyogenes and Streptococcus agalactiae strains was evaluated for the first time, presenting an MIC of 16 µg/mL for both strains. Our findings reveal the antibacterial, antibiofilm, and modulatory potential of tt-farnesol to aid in the fight against infectious processes.
Collapse
|
23
|
Huai Z, Yang H, Sun Z. Binding thermodynamics and interaction patterns of human purine nucleoside phosphorylase-inhibitor complexes from extensive free energy calculations. J Comput Aided Mol Des 2021; 35:643-656. [PMID: 33759016 DOI: 10.1007/s10822-021-00382-w] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Accepted: 03/13/2021] [Indexed: 11/29/2022]
Abstract
Human purine nucleoside phosphorylase (hPNP) plays a significant role in the catabolism of deoxyguanosine. The trimeric protein is an important target in the treatment of T-cell cancers and autoimmune disorders. Experimental studies on the inhibition of the hPNP observe that the first ligand bound to one of three subunits effectively inhibits the protein, while the binding of more ligands to the subsequent sites shows negative cooperativities. In this work, we performed extensive end-point and alchemical free energy calculations to determine the binding thermodynamics of the trimeric protein-ligand system. 13 Immucillin inhibitors with experimental results are under calculation. Two widely accepted charge schemes for small molecules including AM1-BCC and RESP are adopted for ligands. The results of RESP are in better agreement with the experimental reference. Further investigations of the interaction networks in the protein-ligand complexes reveal that several residues play significant roles in stabilizing the complex structure. The most commonly observed ones include PHE200, GLU201, MET219, and ASN243. The conformations of the protein in different protein-ligand complexes are observed to be similar. We expect these insights to aid the development of potent drugs targeting hPNP.
Collapse
Affiliation(s)
- Zhe Huai
- State Key Laboratory of Precision Spectroscopy, School of Physics and Electronic Science, East China Normal University, Shanghai, 200062, China
| | - Huaiyu Yang
- College of Engineering, Hebei Normal University, Shijiazhuang, 050024, China
| | - Zhaoxi Sun
- State Key Laboratory of Precision Spectroscopy, School of Physics and Electronic Science, East China Normal University, Shanghai, 200062, China.
| |
Collapse
|
24
|
Vlasiou MC, Pafti KS. Screening possible drug molecules for Covid-19. The example of vanadium (III/IV/V) complex molecules with computational chemistry and molecular docking. ACTA ACUST UNITED AC 2021; 18:100157. [PMID: 33553857 PMCID: PMC7846477 DOI: 10.1016/j.comtox.2021.100157] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2020] [Revised: 01/11/2021] [Accepted: 01/21/2021] [Indexed: 01/06/2023]
Abstract
We are still facing a Covid-19 pandemic these days and after the aggressively infection control measures taken by the governments in the whole world, there is a need of a rapid pharmaceutical solution in order to control this crisis. The computer aided chemistry and molecular docking is a rapid tool for drug screening and investigation. Moreover, more metal-based drugs are tested daily by research institutes for their antiviral activity. Here, we make use of theoretical studies on previously published biological active complex molecules of vanadium as an example of evaluating possible drug candidates before entering the laboratory. We used DFT calculation studies for structural elucidation and optimization of the molecules and molecular docking studies on several Covid-19 related proteins. Our findings suggest that drug discovery should always be computer -aided. Additionally, it is found that Vtocdea and VXn molecules are seem to be good candidates for further studies as antiviral agents.
Collapse
Affiliation(s)
- Manos C Vlasiou
- Department of Life and Health Sciences, University of Nicosia 46 Makedonitissas Avenue, CY-2417 P.O. Box 24005 Nicosia, Cyprus
| | - Kyriaki S Pafti
- Department of Life and Health Sciences, University of Nicosia 46 Makedonitissas Avenue, CY-2417 P.O. Box 24005 Nicosia, Cyprus
| |
Collapse
|
25
|
de Sá ÉRA, Costa AN, Costa RKM, Souza JL, Ramos RM, Lima FDCA. In silico study of the interactions of Pilocarpus microphyllus imidazolic alkaloids with the main protease (Mpro) of SARS-CoV-2. MOLECULAR SIMULATION 2021. [PMCID: PMC7814572 DOI: 10.1080/08927022.2021.1873321] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
The disease outbreak caused by SARS-CoV-2 continues to rise worldwide, even in countries which have considered it controlled. As new cases appear daily, infecting millions of people and causing thousands of deaths, the current in silico study aims to investigate the imidazolic alkaloids of the species Pilocarpus microphyllus (Jaborandi) as a potential inhibitory activity against the Mpro protease from SARS-CoV-2, since it plays a fundamental role in the processing of polyproteins that are translated from viral RNA. Jaborandi is distributed in some Brazilian biomes, being easily identified, yet little researched, with proven anti-inflammatory, contraceptive, anti-diabetic and gastroprotective activities. In this work, DFT calculation of thermodynamic properties, electrostatic potential surface, frontier molecular orbitals and descriptors of chemical reactivity of imidazolic alkaloids were associated with the use of molecular docking techniques, molecular dynamics and ADMET predictions. One can verify a good reactivity chemistry and energetic stability of epiisopiloturine, epiisopilosine, isopilosine and e pilosine with some residues of amino acids present in the active site of the main protease of COVID-19. In this sense, the results point out to the imidazolic alkaloids of Jaborandi as promising targets for in vitro and in vivo tests, as possible candidates for inhibitors of the enzyme Mpro.
Collapse
Affiliation(s)
- Ézio R. A. de Sá
- Federal Institute of Education, Science and Technology of Piauí, IFPI, Picos, Brazil
| | - Allan N. Costa
- Federal Institute of Education, Science and Technology of Pará, IFPA, Conceição do Araguaia, Brazil
| | - Rayla K. M. Costa
- Research Laboratory of the Computational Quantum Chemistry and Drug Planning Group, Chemistry Department, State Univerty of Piauí, GQQC&PF/UESPI, Teresina, Brazil
| | - Janilson L. Souza
- Federal Institute of Education, Science and Technology of Maranhão, IFMA, Bacabal, Brazil
| | - Ricardo M. Ramos
- Research Laboratory in Information Systems, Information Department, Environment, Health and Food Production, Federal Institute of Education, Science and Technology of Piauí, LaPeSI/IFPI, Teresina, Brazil
| | - Francisco das C. A. Lima
- Research Laboratory of the Computational Quantum Chemistry and Drug Planning Group, Chemistry Department, State Univerty of Piauí, GQQC&PF/UESPI, Teresina, Brazil
| |
Collapse
|
26
|
Ribeiro FDOS, de Araújo GS, Mendes MGA, Daboit TC, Brito LM, Pessoa C, de Lima LRM, de Paula RCM, Bastos RS, Rocha JA, de Brito Sa E, de Oliveira TC, de Jesus Oliveira AC, Sobrinho JLS, de Souza de Almeida Leite JR, de Araújo AR, da Silva DA. Structural characterization, antifungal and cytotoxic profiles of quaternized heteropolysaccharide from Anadenanthera colubrina. Int J Biol Macromol 2020; 165:279-290. [DOI: 10.1016/j.ijbiomac.2020.09.087] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Revised: 09/11/2020] [Accepted: 09/13/2020] [Indexed: 12/17/2022]
|
27
|
Bahuguna A, Bharadwaj S, Chauhan AK, Kang SC. Inhibitory insights of strawberry (Fragaria × ananassa var. Seolhyang) root extract on tyrosinase activity using computational and in vitro analysis. Int J Biol Macromol 2020; 165:2773-2788. [PMID: 33470201 DOI: 10.1016/j.ijbiomac.2020.10.135] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2020] [Revised: 10/15/2020] [Accepted: 10/15/2020] [Indexed: 02/04/2023]
Abstract
The strawberry (Fragaria × ananassa var. seolhyang) is commonly used as fruit but medicinal importance for the non-edible roots which contained a pool of bioactive compounds are not yet studied against tyrosinase inhibition. This study demonstrates the potential of bioactive compounds in root and rhizome of strawberry against tyrosinase inhibition using in silico and in vitro approaches. ADMET profiling and molecular docking analysis show druglikeness for the major bioactive compounds in strawberry root extract (SRE), i.e. procyanidin, procyanidin trimer, kaempferol 3-O-(4-O-p-coumaroyl)-glucoside, neochlorogenic acid, procyanidin tetramer, and quercetin-3-O-pentoside, and docking score between -7.8 to -6.3 kcal/mol with tyrosinase, respectively. Also, these docked complexes exhibit substantial stability contributed by strong hydrogen bonding, hydrophobic interactions, and polar interactions in 100 ns molecular dynamics simulation; further supported by essential dynamics and dynamic cross-correlation matrix analysis. Also, in vitro functional assays support in silico predicted results in terms of substantial cytoprotective and cellular antioxidant potential in Raw 264.7 macrophages challenged by H2O2 as well as non-significant toxicity in zebrafish. SRE exhibits the lowest (5.8%) and highest (42.8%) inhibition of tyrosinase at 100 and 500 μg/ml concentrations, respectively. These results advocated functional properties and tyrosinase inhibition potential of SRE; and hence, SRE can be used in medicinal or cosmetic applications.
Collapse
Affiliation(s)
- Ashutosh Bahuguna
- Department of Biotechnology, Daegu University, Kyoungsan, Kyoungbook 712-714, Republic of Korea; Department of Food Science and Technology, Yeungnam University, Gyeongsan, Gyeongsangbuk-do 38541, Republic of Korea
| | - Shiv Bharadwaj
- Nanotechnology Research and Application Center, Sabanci University, Istanbul 34956, Turkey
| | - Anil Kumar Chauhan
- Department of Biotechnology, Daegu University, Kyoungsan, Kyoungbook 712-714, Republic of Korea; Department of Radiology, School of Medicine, Ohio State University, Columbus, OH 43210, USA
| | - Sun Chul Kang
- Department of Biotechnology, Daegu University, Kyoungsan, Kyoungbook 712-714, Republic of Korea.
| |
Collapse
|
28
|
Albino SL, da Silva JM, de C Nobre MS, de M E Silva YMS, Santos MB, de Araújo RSA, do C A de Lima M, Schmitt M, de Moura RO. Bioprospecting of Nitrogenous Heterocyclic Scaffolds with Potential Action for Neglected Parasitosis: A Review. Curr Pharm Des 2020; 26:4112-4150. [PMID: 32611290 DOI: 10.2174/1381612826666200701160904] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2020] [Accepted: 04/24/2020] [Indexed: 11/22/2022]
Abstract
Neglected parasitic diseases are a group of infections currently considered as a worldwide concern. This fact can be attributed to the migration of these diseases to developed and developing countries, associated with therapeutic insufficiency resulted from the low investment in the research and development of new drugs. In order to overcome this situation, bioprospecting supports medicinal chemistry in the identification of new scaffolds with therapeutically appropriate physicochemical and pharmacokinetic properties. Among them, we highlight the nitrogenous heterocyclic compounds, as they are secondary metabolites of many natural products with potential biological activity. The objective of this work was to review studies within a 10-year timeframe (2009- 2019), focusing on the pharmacological application of nitrogen bioprospectives (pyrrole, pyridine, indole, quinoline, acridine, and their respective derivatives) against neglected parasitic infections (malaria, leishmania, trypanosomiases, and schistosomiasis), and their application as a template for semi-synthesis or total synthesis of potential antiparasitic agents. In our studies, it was observed that among the selected articles, there was a higher focus on the attempt to identify and obtain novel antimalarial compounds, in a way that an extensive amount of studies involving all heterocyclic nitrogen nuclei were found. On the other hand, the parasites with the lowest number of publications up until the present date have been trypanosomiasis, especially those caused by Trypanosoma cruzi, and schistosomiasis, where some heterocyclics have not even been cited in recent years. Thus, we conclude that despite the great biodiversity on the planet, little attention has been given to certain neglected tropical diseases, especially those that reach countries with a high poverty rate.
Collapse
Affiliation(s)
- Sonaly L Albino
- Universidade Estadual da Paraiba, R. Baraunas, 351, Cidade Universitaria, Campina Grande, Paraiba, 58429-500, Brazil
| | - Jamire M da Silva
- Universidade Federal de Pernambuco, Av. Prof. Moraes Rego 1235, Cidade Universitaria, Recife, Pernambuco, 50670-901, Brazil
| | - Michelangela S de C Nobre
- Universidade Federal de Pernambuco, Av. Prof. Moraes Rego 1235, Cidade Universitaria, Recife, Pernambuco, 50670-901, Brazil
| | - Yvnni M S de M E Silva
- Universidade Estadual da Paraiba, R. Baraunas, 351, Cidade Universitaria, Campina Grande, Paraiba, 58429-500, Brazil
| | - Mirelly B Santos
- Universidade Estadual da Paraiba, R. Baraunas, 351, Cidade Universitaria, Campina Grande, Paraiba, 58429-500, Brazil
| | - Rodrigo S A de Araújo
- Universidade Estadual da Paraiba, R. Baraunas, 351, Cidade Universitaria, Campina Grande, Paraiba, 58429-500, Brazil
| | - Maria do C A de Lima
- Universidade Federal de Pernambuco, Av. Prof. Moraes Rego 1235, Cidade Universitaria, Recife, Pernambuco, 50670-901, Brazil
| | - Martine Schmitt
- Universite de Strasbourg, CNRS, LIT UMR 7200, Laboratoire d'innovation therapeutique, Illkirch, France
| | - Ricardo O de Moura
- Universidade Federal de Pernambuco, Av. Prof. Moraes Rego 1235, Cidade Universitaria, Recife, Pernambuco, 50670-901, Brazil
| |
Collapse
|
29
|
Bharadwaj S, Rao AK, Dwivedi VD, Mishra SK, Yadava U. Structure-based screening and validation of bioactive compounds as Zika virus methyltransferase (MTase) inhibitors through first-principle density functional theory, classical molecular simulation and QM/MM affinity estimation. J Biomol Struct Dyn 2020; 39:2338-2351. [PMID: 32216596 DOI: 10.1080/07391102.2020.1747545] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Recent Zika virus (ZIKV) outbreak and association with human diseases such as neurological disorders have raised global health concerns. However, in the absence of an approved anti-ZIKV drug has generated urgency for the drug development against ZIKV infection. Here, structure-based virtual screening of 8589 bioactive compounds, screened at the substrate-binding site of ZIKV nonstructural 5 (NS5)-based structure N-terminal methyltransferase (MTase) domain followed by ADMET (absorption, distribution, metabolism, excretion and toxicity) profiling concluded the four potential lead inhibitors, i.e. (4-acetylamino-benzenesulfonylamino)-acetic acid (F3342-0450), 3-(5-methylfuran-2-yl)-N-(4-sulfamoylphenyl)propanamide (F1736-0142), 8-(2-hydroxy-ethylamino)-1,3-dimethyl-7-(3-methyl-benzyl)-3,7-dihydro-purine-2,6-dione (F0886-0080) and N-[4-(aminosulfonyl)phenyl]-2,3-dihydro-1,4-benzodioxine-2-carboxamide (F0451-2187). Collectively, extra precision docking and Density Functional Theory(DFT) calculations studies identified the F3342-0450 molecule, having strong interactions on the active site of MTase, further supported by molecular dynamics simulation, binding affinity and hybrid QM/MM calculations, suggest a new drug molecule for the antiviral drug development against ZIKV infection. Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Shiv Bharadwaj
- Sabanci University Nanotechnology Research and Application Center, Istanbul, Turkey
| | - Akhilesh Kumar Rao
- Department of Physics, Deen Dayal Upadhyay Gorakhpur University, Gorakhpur, India
| | - Vivek Dhar Dwivedi
- Centre for Bioinformatics, Computational and Systems Biology, Pathfinder Research and Training Foundation, Greater Noida, India
| | - Sarad Kumar Mishra
- Department of Biotechnology, Deen Dayal Upadhyaya Gorakhpur University, Gorakhpur, India
| | - Umesh Yadava
- Department of Physics, Deen Dayal Upadhyay Gorakhpur University, Gorakhpur, India
| |
Collapse
|
30
|
Dwivedi VD, Bharadwaj S, Afroz S, Khan N, Ansari MA, Yadava U, Tripathi RC, Tripathi IP, Mishra SK, Kang SG. Anti-dengue infectivity evaluation of bioflavonoid from Azadirachta indica by dengue virus serine protease inhibition. J Biomol Struct Dyn 2020; 39:1417-1430. [DOI: 10.1080/07391102.2020.1734485] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Vivek Dhar Dwivedi
- Faculty of Science and Environment, Mahatma Gandhi Chitrakoot Gramodaya Vishwavidyalaya, Chitrakoot, Satna, India
- Center for Bioinformatics, Computational and System Biology, Pathfinder Research and Training Foundation, India
| | - Shiv Bharadwaj
- Department of Biotechnology, Institute of Biotechnology, College of Life and Applied Sciences, Yeungnam University, Gyeongsan, Gyeongbuk, Republic of Korea
| | - Sumbul Afroz
- Department of Biotechnology, School of Life Science, University of Hyderabad, India
| | - Nooruddin Khan
- Department of Biotechnology, School of Life Science, University of Hyderabad, India
| | | | - Umesh Yadava
- Department of Physics, Deen Dayal Upadhyay Gorakhpur University, Gorakhpur, India
| | - Ramesh Chandra Tripathi
- Faculty of Science and Environment, Mahatma Gandhi Chitrakoot Gramodaya Vishwavidyalaya, Chitrakoot, Satna, India
| | - Indra Prasad Tripathi
- Faculty of Science and Environment, Mahatma Gandhi Chitrakoot Gramodaya Vishwavidyalaya, Chitrakoot, Satna, India
| | - Sarad Kumar Mishra
- Department of Biotechnology, Deen Dayal Upadhyay Gorakhpur University, Gorakhpur, India
| | - Sang Gu Kang
- Department of Biotechnology, Institute of Biotechnology, College of Life and Applied Sciences, Yeungnam University, Gyeongsan, Gyeongbuk, Republic of Korea
| |
Collapse
|
31
|
Toropova AP, Toropov AA. Whether the Validation of the Predictive Potential of Toxicity Models is a Solved Task? Curr Top Med Chem 2019; 19:2643-2657. [PMID: 31702504 DOI: 10.2174/1568026619666191105111817] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2019] [Revised: 09/02/2019] [Accepted: 09/04/2019] [Indexed: 12/23/2022]
Abstract
Different kinds of biological activities are defined by complex biochemical interactions, which are termed as a "mathematical function" not only of the molecular structure but also for some additional circumstances, such as physicochemical conditions, interactions via energy and information effects between a substance and organisms, organs, cells. These circumstances lead to the great complexity of prediction for biochemical endpoints, since all "details" of corresponding phenomena are practically unavailable for the accurate registration and analysis. Researchers have not a possibility to carry out and analyse all possible ways of the biochemical interactions, which define toxicological or therapeutically attractive effects via direct experiment. Consequently, a compromise, i.e. the development of predictive models of the above phenomena, becomes necessary. However, the estimation of the predictive potential of these models remains a task that is solved only partially. This mini-review presents a collection of attempts to be used for the above-mentioned task, two special statistical indices are proposed, which may be a measure of the predictive potential of models. These indices are (i) Index of Ideality of Correlation; and (ii) Correlation Contradiction Index.
Collapse
Affiliation(s)
- Alla P Toropova
- Laboratory of Environmental Chemistry and Toxicology, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via La Masa 19, 20156 Milano, Italy
| | - Andrey A Toropov
- Laboratory of Environmental Chemistry and Toxicology, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via La Masa 19, 20156 Milano, Italy
| |
Collapse
|
32
|
Spectroscopic (FT-IR, FT-Raman, UV–Vis), quantum chemical calculation and molecular docking evaluation of liquiritigenin: an influenza A (H1N1) neuraminidase inhibitor. RESEARCH ON CHEMICAL INTERMEDIATES 2019. [DOI: 10.1007/s11164-018-03727-7] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|